ISSN: 0213-005X

Indexed in:

Index Current Contents/Clinical Medicine, JCR, SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, CANCERLIT, SCOPUS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

2.6

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

2.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.355

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.381

View more metrics

Journal Information

Back to article

Statistics

Follow this link to access the full text of the article

Scientific letter

HIV infection in the setting of PrEP: Development of antiretroviral resistance and breakthrough infection. Report of two cases in real-life

Infección por el VIH en el contexto de la PrEP: desarrollo de resistencia a los fármacos antirretrovirales e infección de brecha. Descripción de 2 casos en la vida real

Ivan Chivitea,1, Josep Riera-Monroigb,1, Juan Ambrosionia,2, Montserrat Lagunoa,2,

Corresponding author

mlaguno@clinic.cat

Corresponding author.

a HIV Unit, Infectious Diseases Service, Hospital Clínic de Barcelona, Barcelona, Spain

b Dermatology Service, Hospital Clínic de Barcelona, Barcelona, Spain

Read

1982

Times
was read the article

301

Total PDF

1681

Total HTML

Share statistics

Article information

ISSN: 0213005X
Original language: English

DOI:10.1016/j.eimc.2021.11.001

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 September	27	24	51
2024 August	42	20	62
2024 July	55	4	59
2024 June	32	3	35
2024 May	37	8	45
2024 April	26	50	76
2024 March	43	5	48
2024 February	40	2	42
2024 January	52	4	56
2023 December	37	4	41
2023 November	39	5	44
2023 October	68	20	88
2023 September	33	2	35
2023 August	39	0	39
2023 July	77	3	80
2023 June	67	2	69
2023 May	48	7	55
2023 April	633	25	658
2023 March	47	7	54
2023 February	23	2	25
2023 January	18	3	21
2022 December	25	15	40
2022 November	41	13	54
2022 October	4	2	6
2022 August	2	4	6
2022 July	3	4	7
2022 June	84	35	119
2022 May	39	18	57
2022 March	0	2	2
2022 February	0	2	2
2021 December	0	6	6

Show all

Follow this link to access the full text of the article

Publish in

Enfermedades Infecciosas y Microbiología Clínica

Free access articles

Uncommon lip lesions in an HIV...

10.1016/j.eimc.2024.06.017

Tolerance of Atovacuona/proguanil in off-label...

10.1016/j.eimc.2024.06.012

La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter